Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin Irritation
REACH_not irritating | Human skin model | OECD Draft Guideline | #key study#
Eye Irritation
REACH_not irritating | OECD 492 EpiOcular | #key study#
REACH_not irritating | HET-CAM | #key study#
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: ECVAM Skin Irritation Validation Study
- Principles of method if other than guideline:
- This study was conducted using a reconstruced human epidermis model and was in accordance with the following references:
- ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Integrity Funktion Test (Altern Lab Anim. 2007 Dec; 35 (6): 559-601.
- European Commission: Institute for Health and Consumer Protection and European Centre for the Validation of Alternative Methods (ECVAM): Statement on the validity of in vitro tests for skin irritation (2007) - GLP compliance:
- yes (incl. QA statement)
- Test system:
- human skin model
- Remarks:
- EpiSkin Standard Model
- Source species:
- human
- Cell type:
- non-transformed keratinocytes
- Cell source:
- skin obtained from plastic surgery from multiple donors
- Source strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Control samples:
- yes, concurrent negative control
- yes, concurrent positive control
- Amount/concentration applied:
- 15 µL
- Duration of treatment / exposure:
- 15 min
- Duration of post-treatment incubation (if applicable):
- 42 h
- Number of replicates:
- 3
- Irritation / corrosion parameter:
- other: Optical density (OD)
- Run / experiment:
- Time point: 15 min
- Value:
- 0.85
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 0.82
- Positive controls validity:
- valid
- Remarks:
- 0.13
- Remarks on result:
- other:
- Remarks:
- Max. score: 1.6
- Irritation / corrosion parameter:
- other: Rel. Absorbance
- Run / experiment:
- Time point: 15 min.
- Value:
- 104
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100.0
- Positive controls validity:
- valid
- Remarks:
- 16.2
- Other effects / acceptance of results:
- no other effects
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Classification: not irritating
- Executive summary:
In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item Sa 190 is not irritant to skin.
This in vitro study was performed to assess the irritation potential of Sa 190 by means of the Human Skin Model Test.
Three tissues of the human skin model EPISKIN were treated with either the test item, the negative or the positive control for 15 minutes.
15 μL of the melted test item were applied to each tissue and spread to match the tissue size.
15 μL of either the negative control (deionised water) or the positive control (5% Sodium lauryl sulfate) were applied to each tissue.
The test item as well as the positive and negative controls were washed off the skin tissues after 15 minutes treatment. After further incubation for 42 hours the tissues were treated with the MTT solution for 3 hours following 72 hours 10 minutes extraction of the colorant from the cells. The amount of extracted colorant was determined photometrically at 570 nm.
After treatment with the negative control the absorbance values were well above the required acceptability criterion of mean OD ≥ 0.6 for the 15 minutes treatment interval thus showing the quality of the tissues.
Treatment with the positive control induced a sufficient decrease in the relative absorbance as compared to the negative control for the 15 minutes treatment interval thus ensuring the validity of the test system.
The standard deviations between the % variabilities of the test item, the positive and negative controls were below 18% thus ensuring the validity of the study.
The control values are well in the range of our historical data (see chapter 12).
After treatment with the test item Sa 190 the mean relative absorbance value did not decrease (104.0%) compared to the negative control. This value is well above the threshold for irritancy of ≤ 50%. Therefore, the test item is not considered to possess an irritant potential.
In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item Sa 190 is not irritant to skin.
Reference
Dose group |
Treatment Interval |
Absorbance 570 nm Tissue 1* |
Absorbance 570 nm Tissue 2* |
Absorbance 570 nm Tissue 3* |
Mean Absorbance of 3 Tissues |
Standard Deviation of 3 Tissues |
Rel. Absorbance [% of Negative Control]** |
Standard Deviation [%] |
Negative Control |
15 min |
0.8909 |
0.8028 |
0.7786 |
0.8241 |
0.0591 |
100.0 |
7.2 |
Positive Control |
15 min |
0.1243 |
0.1320 |
0.1432 |
0.1331 |
0.0095 |
16.2 |
1.2 |
Sa 190 |
15 min |
0.8821 |
0.7955 |
0.8939 |
0.8571 |
0.0537 |
104.0 |
6.5 |
* Mean of two replicate wells after blank correction /
** relative absorbance [rounded values]:100 (absorbancetest item)/ (absorbancenegative control)
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-12-19 to 2018-01-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline for the Testing of Chemicals No. 492: Reconstructed human Cornea-like Epithelium (RhCE) test method for identifying chemicals not requiring classification and labelling for eye irritation ornea-like Epithelium (RhCE) test method)
- Version / remarks:
- 28 July 2015
- Qualifier:
- according to guideline
- Guideline:
- other: EURL ECVAM DB-ALM Method Summary No. 164: EpiOcular™ Eye Irritation Test - Summary
- Version / remarks:
- 22 July 2015
- Qualifier:
- according to guideline
- Guideline:
- other: EpiOcular™ Eye Irritation Test (OCL-200-EIT) For the prediction of acute ocular irritation of chemicals For use with MatTek Corporation’s Reconstructed Human EpiOcular™ Model irritation of chemicals
- Version / remarks:
- 29 June 2015
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- (Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Germany)
- Species:
- other: Reconstructed human cornea-like epithelium (RhCE) EpiOcular
- Details on test animals or tissues and environmental conditions:
- The test was carried out with the EpiOcular™ reconstructed human cornea-line epithelium (RhCE) model (MatTek). The model consists of normal, human-derived epidermal keratinocytes which have been cultured to form a stratified, highly differentiated squamous epithelium morphologically similar to that found in a human cornea. The EpiOcular™ RhCE tissue construct consists of at least 3 viable layers of cells and a non-keratinised surface, showing a cornea-like structure analogous to that found in vivo.
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 1. Negative Control 50 μL Aqua dest.
2. Positive Control 50 μL methyl acetate
3. Test Item 50 μL (undiluted) - Duration of treatment / exposure:
- 30 +/- 2 min.
- Duration of post- treatment incubation (in vitro):
- - post soak incubation: 12 +/- 2 min.
- post treatment incubation: 120 +/- 15min
- MTT incubation: 3h - Number of animals or in vitro replicates:
- The test was performed on a total of 2 tissues per dose group.
- Details on study design:
- The test was performed on EpiOcular, a reconstituted three-dimensional human corneal epithelium model. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 30 min exposure period and 120 min post-treatment period and compared to those of the concurrent negative controls.
- Irritation parameter:
- other: Mean relative tissue viability [%]
- Run / experiment:
- Mean tissues 1 and 2
- Value:
- 97.9
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 100
- Positive controls validity:
- valid
- Remarks:
- 20.5
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- TEST ACCEPTANCE CRITERIA
Value Cut off pass/fail
Mean Absolute OD570 nm NK 1.814 0.8 < NK < 2.5 pass
Mean Relative Viability PC [%] 20.5 < 50% pass
Max. Difference of % Viability [%] 1.4 < 20% pass - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study under the given conditions the test item showed no irritant effects. The test item is classified as “non-irritant“ in accordance with UN GHS “No Category”
- Executive summary:
In the present study the eye irritating potential of Sa 190 was analysed. Since irritant substances are cytotoxic to the corneal epithelium after a short time exposure the cytotoxic effects of the test item on EpiOcular™, a reconstituted three-dimensional human corneal epithelium model, were determined. Hereby, the test item was applied topically. Cytotoxicity is expressed as the reduction of mitochondrial dehydrogenase activity measured by formazan production from MTT after a 30 min exposure period and 120 min post-treatment period and compared to those of the concurrent negative controls.
The test item showed no irritant effects. The mean relative tissue viability (% negative control) was > 60% (97.9%; NSMTT-,NSCliving and NSCkilled-corrected).
The controls confirmed the validity of the study. The mean absolute OD570of the two negative control tissues was > 0.8 and < 2.5 (1.814). The mean relative tissue viability (% negative control) of the positive control was < 50% (20.5%). The maximum inter tissue difference of replicate tissues of all dose groups was < 20% (1.4%).
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test procedure according to validation study and GLP
- Qualifier:
- according to guideline
- Guideline:
- other: HET-CAM Test
- Principles of method if other than guideline:
- This study was conducted according to the procedures indicated by the folowing internationally accepted guideline and recomendation:
INVITTOX Protocol No. 47: HET-CAM Test. http://ecvam-sis.jrc.it - GLP compliance:
- yes (incl. QA statement)
- Species:
- other: HET-CAM
- Strain:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- For each replicate about 300 µl of the test item were applied directly to the chorioallantoic membrane in order to cover at least 50 % of the membrane. 300 µl of each of the positive controls ( 1% solution in deion. water) and the negative control (physiological sodium chloride solution, 0.9% w/w) were applied to three eggs each.
- Duration of treatment / exposure:
- 300 s
- Observation period (in vivo):
- 300 s
- Number of animals or in vitro replicates:
- - test item: 6
- controls: 3 each - Details on study design:
- CAM Preparation
On day 9, the day of the performance of the experiment, the eggs were candled once again in order to determine the position of the egg's oxygen bubble. The position was marked on the eggshell. Along the marking the eggshell was sawed with an electric saw. Afterwards, the shell above the oxygen bubble was removed. The egg skin beneath was covered with 0.9% (w/v) NaCl in deion. water (saline, produced in-house) in order to separate the egg skin from the chorioallantoic membrane beneath the skin. After 3 minutes incubation at 37.5 ± 0.5 °C the egg skin was removed from the membrane using forceps.
Treatment
In this HET-CAM assay the test item was tested pure. Six eggs were treated with the test item.
For each replicate about 300 μL of the test item were applied directly to the membrane in order to cover at least 50% of the membrane. 300 μL of each of the positive controls and the negative control were applied to three eggs each. During the observation period of 300 seconds any lesions in close proximity to the covered membrane were monitored and recorded.
Observations
The membranes of the eggs were observed for 300 seconds. Lesions of the underlying blood vessels were monitored and noted. In particular three endpoints were observed and the time point at which an effect occurs was recorded. The three endpoints were:
• haemorrhage
• coagulation
• lysis of the blood vesse - Irritation parameter:
- in vitro irritation score
- Run / experiment:
- HET-CAM 300 s
- Value:
- 0
- Vehicle controls validity:
- not applicable
- Negative controls validity:
- valid
- Remarks:
- 0
- Positive controls validity:
- valid
- Remarks:
- 9.92 (DDS); 19.12 (NaOH)
- Other effects / acceptance of results:
- no other effects
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Criteria used for interpretation of results: INVITTOX
- Conclusions:
- Classification: not irritating
- Executive summary:
In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item Sa 190 does not possess any irritating potential.
This in vitro study was performed to assess the irritating potential of SAT 080004 by detection of damages in blood vessels under the chorioallantoic membrane of chicken eggs incubated for 9 days (Hen's Egg Test - Chorioallantoic Membrane Test, HET-CAM.
The test item was tested pure.
The observation time was 5 minutes at room temperature.
Physiological sodium chloride solution (0.9 % (w/v)) was used as negative control.
The negative control showed no irritating effect on the blood vessels under the membrane (mean irritancy index 0.00).
1 % solution of sodium dodecyl sulphate (SDS) and 0.1 N sodium hydroxid (NaOH) were used as positive controls.
The positive controls induced severe irritation on the blood vessels (mean irritancy indices of 9.92 for SDS and 19.12 for NaOH).
The mean irritancy indices of the controls are well comparable with the historical control values and are within the acceptance criteria. Therefore, it was concluded that the test was valid.
No irritating effects were observed during 5 min incubation with the test substance Sa 190. The calculated mean irritancy index is 0.00.
Referenceopen allclose all
The mixture of 50 µl test item per 1 mL MTT medium showed reduction of MTT as compared to the solvent. The mixture turned blue/purple. Since the mean relative tissue viability of the test item treated tissues (TM) was above the 60% threshold value killed tissue controls were performed for quantitative correction of results
NSMTT [%] = [(ODKT- ODKU)/ODNK] * 100 = 0.99%
Difference of NSMTT of the two duplicate tissues must be < 20%, otherwise not accepted.
NSMTT1 [%] = [meanODKT1 - ODKU)/ODNK] * 100 = -0.34%
NSMTT2 [%] = [meanODKT2 - ODKU)/ODNK] * 100 = 2.32%
NSMTT1 - NSMTT2 =± 2.66%
NSMTT was ≤ 60% (0.99%) relative to the negative control of living epidermis and could therefore be used for determination of the killed control corrected viability (KCCV) according to the following formula:
KCCV [%] = viabilityTM- NSMTT = 97.0%
The mixture of 50 µL test item per 1 mL A. dest showed colouring as compared to the solvent. Since the mean relative tissue viability of the test item treated tissues (TM) was above the 60% threshold value coloured tissue controls were performed for quantitative correction of results.
NSCliving [%] = [ODTVT/ODNK]*100 = 0.47%
Difference of NSCliving of the two duplicate tissues must be < 20%, otherwise not accepted.
NSC1 [%] = [ODTVT1/ODNK] * 100 = 0.39%
NSC2 [%] = [ODTVT2/ODNK] * 100 = 0.54%
NSC1 – NSC2 = ±0.15%
NSClivingwas ≤ 60% (0.47%) relative to the negative control of living epidermis and could therefore be used for determination of theNSC-corrected mean relative tissue viability (NSCCV) according to the following formula:
NSCCV [%] = viabilityTM[%] – NSCliving[%] = 96.4%
Since the test item showed non-specific MTT-reduction and non-specific colouring of living tissues, a third control for non-specific colour in killed tissues (NSCkilled) was performed to avoid a possible double-correction for colour interference.
The non-specificcolour of additional killed tissues (NSCkilled) was calculated according to the following formula:
NSCkilled [%] = [ODTKT/ODNK]*100 = 1.45%
The true tissue viability was then calculated as the percent tissue viability obtained with living tissues minus NSMTT minus NSClivingplus NSCkilled.
True Tissue Viability = [%] mean tissue viability – NSMTT –NSCliving+ NSCkilled= 97.9%
Result of the Test Item Sa 190
Name |
Negative Control |
Positive Control |
Test item |
|||
Tissue |
1 |
2 |
1 |
2 |
1 |
2 |
OD570values |
1.798 |
1.775 |
0.400 |
0.405 |
1.763 |
1.755 |
1.847 |
1.837 |
0.401 |
0.424 |
1.817 |
1.777 |
|
OD570values |
1.754 |
1.731 |
0.356 |
0.361 |
1.719 |
1.711 |
1.803 |
1.794 |
0.357 |
0.380 |
1.774 |
1.733 |
|
mean of the duplicates |
1.778 |
1.762 |
0.356 |
0.371 |
1.746 |
1.722 |
mean OD |
1.770* |
0.364 |
1.734 |
|||
TODTT- NSMTT |
- |
- |
1.717 |
|||
TODTTNSMTT und NSCliving |
- |
- |
1.707 |
|||
mean sd OD |
0.011 |
0.010 |
0.017 |
|||
tissue viability [%] |
100.5 |
99.5 |
20.1 |
20.9 |
98.6 |
97.3 |
relative tissue viability difference [%]*** |
0.9 |
0.8 |
1.4 |
|||
mean tissue viability [%] |
100.0 |
20.5** |
98.0 |
|||
mean tissue viability [%] |
- |
- |
97.0 |
|||
mean tissue viability [%] |
- |
- |
96.4 |
|||
True Tissue Viability |
- |
- |
97.9 |
* Corrected mean OD570 of the negative control corresponds to 100% absolute tissue viability
** Mean relative tissue viability of the positive control is < 50%
*** Relative tissue viability difference of replicate tissues is < 20%
Result of the NSMTT Control
NSMTT |
KU |
KT |
Negative Control |
||||
Tissue |
1 |
2 |
1 |
2 |
1 |
2 |
|
absolute OD570 -values |
0.074 |
0.075 |
0.067 |
0.115 |
1.798 |
1.775 |
|
0.075 |
0.076 |
0.071 |
0.117 |
1.847 |
1.837 |
||
OD570(Blank Corrected) |
0.030 |
0.031 |
0.023 |
0.071 |
1.754 |
1.731 |
|
0.031 |
0.032 |
0.027 |
0.073 |
1.803 |
1.794 |
||
mean OD570 |
0.031 |
0.031 |
0.025 |
0.072 |
1.778 |
1.762 |
|
total mean OD570 |
0.031 |
0.049 |
1.770 |
||||
SD OD570(of the replicate tissues) |
0.000 |
0.033 |
0.011 |
||||
NSMTT [%] |
0.99 |
- |
|||||
Relative Tissue Viability [%] |
- |
100.5 |
99.5 |
||||
Mean Relative Tissue Viability [%] |
- |
100.0 |
|||||
SD Tissue Viability [%] |
- |
0.6 |
|||||
CV [% Viabilities] |
- |
0.6 |
Result of the NSCliving Control
NSCliving |
TVT |
Negative Control |
|||
Tissue |
1 |
2 |
1 |
2 |
|
absolute OD570 -values |
0.050 |
0.053 |
2.098 |
2.048 |
|
0.051 |
0.055 |
2.111 |
2.021 |
||
absolute OD570 - |
0.007 |
0.010 |
2.055 |
2.005 |
|
0.008 |
0.012 |
2.068 |
1.978 |
||
mean OD570 |
0.008 |
0.011 |
2.062 |
1.991 |
|
total mean OD570 |
0.010 |
2.027 |
|||
SD OD570 |
0.002 |
0.050 |
|||
NSCliving[%] |
0.47 |
- |
|||
Relative Tissue Viability [%] |
- |
101.7 |
98.3 |
||
Mean Relative Tissue Viability [%] |
- |
100.0 |
|||
SD Tissue Viability [%]*** |
- |
2.5 |
|||
CV [% Viabilities] |
- |
2.5 |
Result of the NSCkilled Control
NSCkilled |
TKT |
Negative Control |
|||
Tissue |
1 |
2 |
1 |
2 |
|
Absolute OD570 -values |
0.065 |
0.078 |
2.098 |
2.048 |
|
0.064 |
0.082 |
2.111 |
2.021 |
||
Absolute OD570 - |
0.022 |
0.035 |
2.055 |
2.005 |
|
0.021 |
0.039 |
2.068 |
1.978 |
||
Mean OD570 |
0.022 |
0.037 |
2.062 |
1.991 |
|
Total Mean OD570 |
0.029 |
2.027 |
|||
SD OD570 |
0.011 |
0.050 |
|||
NSCkilled[%] |
1.45 |
- |
|||
Relative Tissue Viability [%] |
- |
101.7 |
98.3 |
||
Mean Relative Tissue Viability [%] |
- |
100.0 |
|||
SD Tissue Viability [%] |
- |
2.5 |
|||
CV [% Viabilities] |
- |
2.5 |
Mean irritancy index of 6 eggs: Test Item = 0.00
Mean irritancy index of 3 eggs:
Positive control (1% Sodium dodecyl sulphate) = 9.92
Positive control (0.1 N Sodium hydroxide solution) = 19.12
Negative control (Physiological sodium chloride solution (0.9%)) = 0.00
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
The test substance did not produce skin irritation and eye irritation. The substance does not need to be classified for irritation according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.